NTI — Neurotech International Balance Sheet
0.000.00%
- AU$25.04m
- AU$22.65m
- AU$0.04m
Annual balance sheet for Neurotech International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.9 | 5.03 | 11.6 | 3.03 | 2.39 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.099 | 0.258 | 0.318 | 0.089 | 0.342 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2.02 | 5.31 | 12.2 | 3.24 | 2.75 |
| Net Property, Plant And Equipment | 0.003 | 0.001 | 0 | 0 | — |
| Total Assets | 2.02 | 5.31 | 12.2 | 3.24 | 2.75 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.593 | 1.35 | 0.315 | 0.286 | 2.14 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.593 | 1.35 | 0.315 | 0.286 | 2.14 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.43 | 3.96 | 11.9 | 2.95 | 0.611 |
| Total Liabilities & Shareholders' Equity | 2.02 | 5.31 | 12.2 | 3.24 | 2.75 |
| Total Common Shares Outstanding |